Business Development Representative - M &A
Start Date: Immediate
Location: Remote / Flexible
Compensation: Target of $120k-140k OTE (50% base / 50% commission) - Uncapped
About us
SSA is a fast-growing founder- and employee-owned acquisition platform in the scientific instrument space revolutionizing the scientist's experience of regulation-mandated services. Our platform primarily provides testing, inspection, and calibration services to pharmaceutical, medical device, and research companies across the United States. We've completed 10 acquisitions to date, and are currently serving over 3,000 customers. We are currently looking into new service offerings where this individual would be directly responsible for building out an acquisition pipeline.
We were recently recognized by Inc. Magazine in their 2024 list of 5,000 fastest growing privately-held companies.
Position
The M&A Business Development Representative (“BDR”) will be working directly with the VP of Strategy and Corporate Development and the Co-Founder / President and be expected to execute the M&A sourcing strategies of the Corporate Development team. This role will allow for great advancement opportunities and learning from experienced leaders in the field.
The ideal candidate will be an experienced hunter in B2B sales (targeted SMB focus) capable of leveraging technology to run broad direct outreach campaigns and managing business broker and investment banker networks for target inbounds. This is a very unique opportunity for a hungry, talented and entrepreneurial individual to join a winning team that continues to build out the platform.
Responsibilities (including but not limited to)
Minimum Qualifications
Benefits
Our Strategy
To date, our strategy has been to build out a platform in the controlled environment testing and certification space (cleanrooms, fume hoods, and biosafety cabinets). We are now at a point to expand beyond our core strategy and look to new niches / verticals to propel our growth. Example niches we are currently considering include: biomedical equipment maintenance and repair, FDA required GLP, GMP, and GCP consulting and auditing, mission-critical scientific consumables, outsourced laboratory testing such as environmental testing, and more.
Our Approach
We differentiate ourselves from other investors and buyers with our employee centric approach, a white-glove seller experience, and a quick / efficient deal close timeline. We have designed a deal process that minimizes leak risk while efficiently conducting acquisition due diligence. Our timeline to close currently stands at less than 30 days once a target is interested.
We have already identified 5-10 new niches, corresponding to 1,000+ potential targets, that this hire will begin working on immediately to qualify new leads. We strive to refill the pipeline consistently, and provide additional niche ideas monthly where we will want this hire to identify and qualify actionable targets. Additionally, we continue to build out our business broker and investment banker relationships.
Seller Priorities
Sellers are typically looking to take a step back from the business (retire) and/or have a financial outcome in mind that they are looking to achieve. They are usually very loyal to their employees and customers and want to see their business placed into good hands. Additionally, they want a process that is simple, quick, and transparent. Because of these reasons, primary criteria sellers have when evaluating a potential buyer include:
Opportunity
**This is a great opportunity for a hungry individual with a passion for entrepreneurship and building businesses. This individual will eventually have the opportunity to grow into Head of Sourcing or another strategic position where he/she will be responsible for building out the sourcing function.
**
**
**